The global nasal cannula market size was significantly robust in 2022 and is expected to register a steady revenue CAGR over the forecast period. Key factors providing impetus to market revenue growth are availability of improved nasal cannulas made of soft materials, increasing incidence of chronic respiratory illnesses, and high acceptance rate of single-use nasal cannulas.
The nasal cannula is a piece of medical equipment that is used to deliver oxygen to patients who are unable to receive enough oxygen for their bodies to operate properly. Chronic Obstructive Pulmonary Disease (COPD), environmental changes, allergy responses, or other respiratory diseases can cause respiratory disorders, thereby boosting the demand for nasal cannulas. Oxygen sources are linked by nasal cannulas. They are inexpensive, are simple to operate, and lightweight. Nasal cannulas have potential uses in hospitals, clinics, at home, and on the road.
Request a Sample@ https://www.qyresearchmedical.com/sample/119439
A nasal cannula is a tiny, flexible tube that is used as a medical device. It has two open prongs that are meant to be inserted inside the patient’s nostrils. These tubes connect to an oxygen source and deliver a continuous stream of medical-grade oxygen via the nose to help patients breathe more easily. Nasal cannulas are used to provide sufficient oxygen to patients with low oxygen concentrations. High-flow cannulas are also available in the market for higher oxygen concentrations. The output from these nasal cannulas is comparable to that of continuous positive airway pressure devices. When compared to other oxygen delivery methods, nasal cannulas are less intrusive. Unlike facemasks, nasal cannulas do not prevent patients from eating or talking normally. Tiny nasal cannulas are also transportable.
Major Factors Driving Growth Of The Global Nasal Cannula Market:
Revenue growth of the global nasal cannula market is significantly driven by increasing prevalence of respiratory illnesses caused due to rising air pollution, changing climatic conditions, surging number of smokers, and changes in lifestyles. Various manufacturers and suppliers worldwide are also responding to the higher acceptance and demand for nasal cannulas. Nasal cannulas are utilized when a low flow, low or medium concentration of oxygen is necessary and the patient is in a stable state. The amount of oxygen inhaled is determined by the patient\’s breathing rate and pattern and they provide oxygen in a variable way. Nasal cannulas help patients with chronic stable respiratory difficulties to eat, drink, and converse while wearing them. They can also reduce the danger of carbon dioxide rebreathing. A basic oxygen mask or a non-rebreathe mask is frequently used in acute circumstances where patients require a greater concentration of oxygen.
Factors Restraining Growth Of The Global Nasal Cannula Market:
The global nasal cannula market growth is substantially hampered by several unfavorable factors. Nasal dryness is a typical side effect of using a nasal cannula because cold, dry oxygen is pumped into the patient’s nostrils. Before taking any type of supplementary oxygen, there are certain dangers to consider. Long-term usage has been associated a condition known as pulmonary oxygen toxicity, which occurs when the body gets too much oxygen and can cause damage to the airways. At the same time, eye and lung damages may also occur, owing to increased usage of nasal cannulas.
Opportunities For Players Operating In The Global Nasal Cannula Market:
Main players in the market are focusing on R&D and technical innovation in order to provide more flexible and comfortable nasal cannulas to patients. It enables increased usage of nasal cannulas in the treatment of a variety of conditions. Growing e-commerce capability and vast distribution networks of companies are helping them to facilitate the availability of items throughout the world. It is therefore leading to a surging acceptance of these products. These factors are expected to boost the nasal cannula market growth.
Global Nasal Cannula Market Revenue Led By Type Segment:
Based on type, the low flow nasal cannula segment is expected to reach the highest revenue share over the forecast period. Low-flow nasal cannulas are becoming more popular in long-term care, ambulatory care, and home care settings. These settings require a low of medium concentration to keep patients in a stable condition. Furthermore, the low flow nasal cannulas are cheaper in terms of price, compared to high flow cannulas. Hence, this segment would acquire a larger market share.
Global Nasal Cannula Market Leading End-use Segment:
Based on end-use, the hospitals segment is expected to dominate all other segments in terms of revenue generation over the forecast period. Major factors contributing to this segment’s growth are the rising number of patients suffering from long-term respiratory distress and increasing geriatric population across the globe. Additionally, rising adoption of high-flow nasal cannulas for severe respiratory distress requiring high flow oxygen is also expected to fuel the expansion of this segment in the nasal cannula market segment in the near future.
North America Accounts For Largest Revenue Share In Global Nasal Cannula Market:
Among regional markets, North America emerged as the largest market for nasal cannula in 2020, with the highest revenue share. Revenue growth in the North American market is mainly attributed to increasing continuous positive airway pressure (CPAP) and non-invasive ventilation (NIV) devices for patients living with respiratory disorders. They are mainly preferring the usage of these devices in home care settings. Also, ongoing technological advancements and present of a well-developed healthcare infrastructure are expected to shape the region’s medical environment. Besides, major companies present in the region are striving persistently to surge their manufacturing capacity of high-flow nasal cannula devices. It is also set to boost growth of the North American market in the upcoming years.
Asia Pacific Continues To Lead In Terms Of Revenue CAGR:
The Asia Pacific nasal cannula market is expected to register the fastest CAGR over the forecast period. Increasing number of local manufacturers, surging healthcare expenditures, rising elderly population, and higher prevalence of COPD & asthma in emerging economies are anticipated to fuel market growth in Asia Pacific during the forecast period.
Major Companies Profiled In The Report:
- Allied Healthcare Products, Inc.
- Teleflex Incorporated
- Flexicare Medical Ltd.
- Vapotherm Inc.
- ResMed Inc.
- Fairmont Medical
- Fisher & Paykel Healthcare Limited
- Well Lead Medical Co. Ltd.
- Salter Labs
Strategies And Objectives Of Major Companies:
- In May 2019, the Optiflow 3S nasal cannula was introduced by Fisher & Paykel Healthcare. The F&P Optiflow 3S nasal cannula is a new range designed for Optiflow nasal high flow treatment delivery. The cannula has innovative features, including breathable headgear, a redesigned philtrum pillow, and side-swapping that. When combined with Fisher & Paykel Healthcare\’s patented Evaqua technology, it turns into the most comfortable and stable nasal cannula the company has ever developed.
What Our Report Provides And Why Our Offering Is Better:
This report offers historical data points and forecasts and revenue growth at a global, regional, and country level, and provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2023 to 2032. The global market report includes industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and market share contribution by each regional and country market. In addition, the report offers industry analysis and competitive landscape, company financials, and impact analysis. The report includes a detailed view of the global market, along with changing dynamics and trends, scenarios, detailed market and regional segmentation, regional landscape, analysis and evaluation, major investments, product offerings, product launches, and details of historical, current, and projected revenues.
Detailed Segmentation In Our Report:
For the purpose of this report, global nasal cannula market is segmented on the basis of type, material, application, end-use, and region:
Type Outlook (Revenue, USD Billion; 2023-2032)
- Low Flow Nasal Cannula
- High Flow Nasal Cannula
Material Outlook (Revenue, USD Billion; 2023-2032)
Application Outlook (Revenue, USD Billion; 2023-2032)
- Cardiovascular Surgery
- Oxygen Therapy
- General Therapy
- Plastic Surgery
- Orthopedic Surgery
End-use Outlook (Revenue, USD Billion; 2023-2032)
- Ambulatory Healthcare Services
- Long Term Care Centers
Region Outlook (Revenue, USD Billion; 2023-2032)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119439/1500
You can place an order or ask any questions, please feel free to contact firstname.lastname@example.org | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: